The goal of the National Association of Cannabis Businesses, based in Washington DC, is to get state marijuana regulators to change their ways.
Regulators have shown a tendency to want to start from scratch when developing rules for new cannabis programs and fail to consult other states’ existing frameworks.
According to a news release, the NACB’s recommendations will address:
While marijuana isn’t fully legalized in the District—recreational sales remain illicit due in large part to congressional interference, and public use is barred under a 2015 law—a new initiative by Mayor Muriel Bowser’s administration is allowing more people to benefit from D.C.’s medical cannabis dispensaries. Under expedited rules that Bowser announced earlier this month, the District now recognizes medical marijuana cards from 27 states where it is legal, up from 19 states before. D.C. officials were also reviewing four other states’ eligibility.
Medical marijuana patients from across the U.S. can now buy their medicine at D.C. dispensaries.
Mayor Muriel Bowser announced Thursday that the list of states with medical marijuana programs whose residents can purchase their pot in D.C. is expanding from 19 to 27, with four more states currently under review. The new states added include Alaska, Arizona, Arkansas, California, Nevada, New Mexico, New York and Vermont.
As New Jersey’s cannabis legalization talks continue behind closed doors — and some speculate they may fall apart — people in the Garden State are still lighting up joints. According to federal government estimates, 22.2 million Americans have used marijuana in the past month. And depending on where you live and buy, the cost can be considerable.
The results, however, have been pretty paltry: Cannabis is still illegal nationwide, businesses still can’t bank or deduct expenses on their taxes like other merchants, and legitimate interstate cannabis commerce remains a distant dream. With few exceptions, bipartisan bills that would de-schedule the drug or give businesses tax relief are still withering in committee without hearings, let alone votes.
New Jersey saw immense progress in 2018, though no certain milestones have been reached just yet. The year began with staunchly anti-cannabis Governor Chris Christie succeeded by a pro-cannabis governor, Phil Murphy. Murphy swore to legalize adult use within the first 100 days of his term. This did not occur.
Dr. Chanda Macias doesn’t have a one-of-a-kind story.
Right now it’s a one-of-146 kind of a story and come November she hopes it’s a one-in-six kind of story.
Macias, the owner and general manager of the National Holistic Healing Center Medical Marijuana Dispensary in Washington, D.C., is one of 146 applicants for the six alternative treatment center (ATC) licenses the New Jersey Department of Health will award in November.
If her Ilera Holistic Healthcare is named one of the licenses, it will deepen her connection to the Garden State.
If it feels like NJ’s medical marijuana program is languishing a bit, that’s because it is. And while Gov Phil Murphy has made some marginal improvements, with a program this bad, baby steps won’t suffice.
Washington DC recently began to honor out-of-state medical cannabis ID cards. I checked out DC’s dispensary scene on a recent visit. Turns out, there’re doing better by patents in DC than we are here in NJ.
Here are 10 lessons lawmakers and regulators could take from DC’s superior example:
With positions hardening by the day in New Jersey, it may be worth considering a third option, which I believe threads the proverbial needle between Rice's position favoring decriminalization and full-scale commercialized legalization embodied by Colorado's initiative and various pending bills in the New Jersey Legislature.